secwatch.observer — SEC 8-K summary
======================================

Issuer:     CARDINAL HEALTH INC (CAH)
CIK:        0000721371
Form:       8-K
Filed at:   2023-11-03T23:59:59+00:00
Accession:  0000721371-23-000083
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cardinal Health Q1 revenue +10% to $54.8B; raises FY24 non-GAAP EPS guidance to $6.75-$7.00
--------------------------------------------------------------------------------

- GAAP operating loss $14M due to $581M Medical goodwill impairment; GAAP diluted EPS $0.02.
- Non-GAAP operating earnings $571M (+35%); non-GAAP diluted EPS $1.73 (+44%) vs. $1.20.
- Pharmaceutical segment profit $507M (+18%); Medical segment profit $71M vs. ($8M) loss.
- FY2024 non-GAAP EPS guidance raised to $6.75-$7.00 from $6.50-$6.75; pharma profit growth outlook raised to 7%-9%.
- Interest and other expense guidance reduced to $100M-$120M; diluted shares ~249M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/721371/000072137123000083/0000721371-23-000083-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/721371/000072137123000083/cah-20231103.htm
  HTML page:      https://secwatch.observer/filing/0000721371-23-000083

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer